Bioinformatics to Identify Novel Cancer Drug Combinations

News   Dec 22, 2016 | Institute for Research in Biomedicine

 
Bioinformatics to Identify Novel Cancer Drug Combinations
 
 
 
 

RELATED ARTICLES

Cambridge Epigenetix, NuGEN Technologies Sign Agreement to Combine Leading Technologies in Epigenetics Research

News

Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.

READ MORE

Why Combining Two Checkpoint Inhibitors is More Effective Than Using Them in Isolation

News

A team at the MD Anderson Cancer center team has found that checkpoint inhibitors fire up different types of T cells to attack tumors

READ MORE

Major Cause of Drug-resistance in Prostate Cancer Patients Identified

News

A recent Nature Medicine paper outlines the role of mutations within the SPOP gene on the development of resistance to one class of drugs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE